Comparison of the effects of 3 different anti-VEGF drugs on cornea thickness, lens thickness and anterior chamber depth
To compare the long-term effects of 3 different anti-VEGF molecules on the lens, cornea and anterior chamber in phakic patients who have received consecutive intravitreal injections. 157 patients who did not have corneal pathology but were treated with 1.25mg/0.05ml intravitreal bevacizumab, 0.5mg/0...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Society of Turaz Bilim
2023-03-01
|
| Series: | Medicine Science |
| Subjects: | |
| Online Access: | https://www.medicinescience.org/?mno=135972 |
| _version_ | 1797316430507540480 |
|---|---|
| author | Mehmet Tahir Eski Kuddusi Teberik Taha Sezer |
| author_facet | Mehmet Tahir Eski Kuddusi Teberik Taha Sezer |
| author_sort | Mehmet Tahir Eski |
| collection | DOAJ |
| description | To compare the long-term effects of 3 different anti-VEGF molecules on the lens, cornea and anterior chamber in phakic patients who have received consecutive intravitreal injections. 157 patients who did not have corneal pathology but were treated with 1.25mg/0.05ml intravitreal bevacizumab, 0.5mg/0.5ml ranibizumab or 2mg/0.05ml aflibercept injections due to diabetic macular edema were retrospectively analyzed in our clinic. Patients who received three consecutive monthly injections were included to the study. Corneal thickness, lens thickness and anterior chamber depth measurements which were taken before the injections, 1 month after the first injection, 1 month after the second injection, and 1 month after the third injection were used in the study. There was no statistical difference between the bevacizumab, ranibizumab, aflibercept and control group in terms of preoperative specifications such as number of patients, gender and age average. A statistically significant difference was found between the 4 anterior chamber depth measurements in the control group, Ranibizumab drug group, and Bevacizumab and Aflibercept drug groups (p [Med-Science 2023; 12(1.000): 76-80] |
| first_indexed | 2024-03-08T03:19:15Z |
| format | Article |
| id | doaj.art-00efcaf87b314e2e9ef263586211a304 |
| institution | Directory Open Access Journal |
| issn | 2147-0634 |
| language | English |
| last_indexed | 2024-03-08T03:19:15Z |
| publishDate | 2023-03-01 |
| publisher | Society of Turaz Bilim |
| record_format | Article |
| series | Medicine Science |
| spelling | doaj.art-00efcaf87b314e2e9ef263586211a3042024-02-12T10:34:07ZengSociety of Turaz BilimMedicine Science2147-06342023-03-01121768010.5455/medscience.2023.01.02135972Comparison of the effects of 3 different anti-VEGF drugs on cornea thickness, lens thickness and anterior chamber depthMehmet Tahir Eski0Kuddusi Teberik1Taha Sezer2Ergenekon mahalle 104. Sokak Private Neon Hospital Erzincan Merkez Orhangazi Mah., Konuralp 500. Cd, No: 125/7, 81450, Duzce, Turkey Orhangazi Mah., Konuralp 500. Cd, No: 125/7, 81450, Duzce, TurkeyTo compare the long-term effects of 3 different anti-VEGF molecules on the lens, cornea and anterior chamber in phakic patients who have received consecutive intravitreal injections. 157 patients who did not have corneal pathology but were treated with 1.25mg/0.05ml intravitreal bevacizumab, 0.5mg/0.5ml ranibizumab or 2mg/0.05ml aflibercept injections due to diabetic macular edema were retrospectively analyzed in our clinic. Patients who received three consecutive monthly injections were included to the study. Corneal thickness, lens thickness and anterior chamber depth measurements which were taken before the injections, 1 month after the first injection, 1 month after the second injection, and 1 month after the third injection were used in the study. There was no statistical difference between the bevacizumab, ranibizumab, aflibercept and control group in terms of preoperative specifications such as number of patients, gender and age average. A statistically significant difference was found between the 4 anterior chamber depth measurements in the control group, Ranibizumab drug group, and Bevacizumab and Aflibercept drug groups (p [Med-Science 2023; 12(1.000): 76-80]https://www.medicinescience.org/?mno=135972bevacizumabafliberceptranibizumabanterior chamber |
| spellingShingle | Mehmet Tahir Eski Kuddusi Teberik Taha Sezer Comparison of the effects of 3 different anti-VEGF drugs on cornea thickness, lens thickness and anterior chamber depth Medicine Science bevacizumab aflibercept ranibizumab anterior chamber |
| title | Comparison of the effects of 3 different anti-VEGF drugs on cornea thickness, lens thickness and anterior chamber depth |
| title_full | Comparison of the effects of 3 different anti-VEGF drugs on cornea thickness, lens thickness and anterior chamber depth |
| title_fullStr | Comparison of the effects of 3 different anti-VEGF drugs on cornea thickness, lens thickness and anterior chamber depth |
| title_full_unstemmed | Comparison of the effects of 3 different anti-VEGF drugs on cornea thickness, lens thickness and anterior chamber depth |
| title_short | Comparison of the effects of 3 different anti-VEGF drugs on cornea thickness, lens thickness and anterior chamber depth |
| title_sort | comparison of the effects of 3 different anti vegf drugs on cornea thickness lens thickness and anterior chamber depth |
| topic | bevacizumab aflibercept ranibizumab anterior chamber |
| url | https://www.medicinescience.org/?mno=135972 |
| work_keys_str_mv | AT mehmettahireski comparisonoftheeffectsof3differentantivegfdrugsoncorneathicknesslensthicknessandanteriorchamberdepth AT kuddusiteberik comparisonoftheeffectsof3differentantivegfdrugsoncorneathicknesslensthicknessandanteriorchamberdepth AT tahasezer comparisonoftheeffectsof3differentantivegfdrugsoncorneathicknesslensthicknessandanteriorchamberdepth |